HCPCS J-code
J9290: obinutuzumab
Obinutuzumab 10 mg (anti-CD20, CLL/FL)
Code
J9290
Generic
obinutuzumab
Brands
Gazyva
Drug class
Biologic drugs (mAbs and biosimilars)
Common denial patterns
- CD20+ confirmed
Frequently asked questions
What is HCPCS J9290?
Obinutuzumab 10 mg (anti-CD20, CLL/FL)
Why does insurance commonly deny J9290?
CD20+ confirmed.
What brand-name drug uses J9290?
Gazyva.
Related
Appeal a J9290 denial
Upload the denial — we draft the appeal letter in 5 minutes citing the right clinical guideline.
Get started →Contact: hello@approvalhelp.com